Enteric Fever, Plague Vaccines From Synthetic Biology Firm Near Clinical Studies
Executive Summary
The oral administration of synthetic thermostable vaccines that use a bacterial vector could enter clinical studies in 2019, funded by VCs interested in their use in emerging markets, where endemic and childhood diseases could yield to the new approach.